Nanobiotix says Goldman Sachs beneficial stake rises to 7.10% of capital, 6.66% voting rights

Goldman Sachs Group, Inc.

Goldman Sachs Group, Inc.

GS

0.00
  • Nanobiotix filing showed Goldman Sachs crossed above 5% on June 8, holding 3,616,141 shares, equal to 7.1% of capital.
  • Stake fell back below 5% on June 9 to 2,392,946 shares, equal to 4.71% of capital.
  • Moves were driven by off-market transactions.
  • Position included share loans with right to recall, falling to 13,087 shares from 464,973 shares.
  • Cash-settled swap exposure stayed broadly steady at about 860,000 shares.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nanobiotix SA published the original content used to generate this news brief on June 12, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.